UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of nuclear cardiology, ISSN 1071-3581, 06/2018, Volume 27, Issue 1, pp. 1 - 10
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1083 - 1083
Journal Article
Expert opinion on pharmacotherapy, ISSN 1465-6566, 03/2016, Volume 17, Issue 5, pp. 735 - 742
HCV | elabsvir | direct-acting antiviral drugs | Grazoprevir | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Hepacivirus - drug effects | Quinoxalines - pharmacokinetics | Benzofurans - therapeutic use | Coinfection | Antiviral Agents - pharmacokinetics | Antiviral Agents - therapeutic use | Humans | Drug Resistance, Viral | Hepacivirus - genetics | Hepatitis C, Chronic - complications | Imidazoles - pharmacokinetics | Renal Insufficiency, Chronic - complications | Hepatitis C, Chronic - drug therapy | Randomized Controlled Trials as Topic | Renal Insufficiency, Chronic - drug therapy | Benzofurans - pharmacokinetics | HIV Infections - complications | HIV Infections - drug therapy | Imidazoles - therapeutic use | Protease Inhibitors - therapeutic use | Drug Combinations | Quinoxalines - therapeutic use | Index Medicus
Journal Article
Annals of internal medicine, ISSN 0003-4819, 07/2010, Volume 153, Issue 2, pp. 135 - 136
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Viral hepatitis | Infectious diseases | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Hepatitis E - drug therapy | Antiviral Agents - therapeutic use | Humans | Middle Aged | Hepatitis E - immunology | Interferon-alpha - therapeutic use | Male | Immunocompromised Host | Chronic Disease
Journal Article
Small (Weinheim an der Bergstrasse, Germany), ISSN 1613-6810, 03/2014, Volume 10, Issue 6, pp. 1116 - 1124
nanomedicine | magnetic resonance imaging | gold nanoparticles | radiosensitization | Materials Science | Materials Science, Multidisciplinary | Physics, Condensed Matter | Science & Technology - Other Topics | Chemistry, Physical | Physics | Science & Technology | Physics, Applied | Physical Sciences | Chemistry | Nanoscience & Nanotechnology | Technology | Chemistry, Multidisciplinary | Gold | Cell Survival | Humans | Rats | Spleen - cytology | Osteosarcoma - diagnosis | Radiation-Sensitizing Agents | Rats, Sprague-Dawley | Magnetic Resonance Imaging | Animals | Contrast Media | Survival Analysis | Brain - pathology | Cell Line, Tumor | Osteosarcoma - pathology | Metal Nanoparticles | Nanoparticles | Magnetic resonance imaging | Radiotherapy | Chelates | Nuclear magnetic resonance--NMR | Radiation therapy | Contrast agents | Irradiation | Position (location) | Tumors | Chemical Sciences
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9973, pp. 1075 - 1086
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Hepacivirus - genetics | Imidazoles - administration & dosage | Benzofurans - administration & dosage | Male | RNA, Viral - blood | Interferons - therapeutic use | Hepatitis C, Chronic - complications | Polyethylene Glycols - therapeutic use | Viral Load | Young Adult | Ribavirin - administration & dosage | Treatment Failure | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Liver Cirrhosis - etiology | Drug Administration Schedule | Quinoxalines - administration & dosage | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Adolescent | Aged | Medical colleges | Protease inhibitors | Proteases | Clinical trials | Product development | Biological response modifiers | Hepatitis C virus | Health aspects | Liver cirrhosis | Ribavirin | Comparative studies | Hepatitis | Genotype & phenotype | Interferon | Drug therapy | Index Medicus | Abridged Index Medicus | Life Sciences | UNITED-STATES | SOFOSBUVIR | RIBAVIRIN | Klinisk medicin | SUSTAINED VIROLOGICAL RESPONSE | Medicine | Clinical Medicine | HCV NS5A INHIBITOR | TREATMENT-EXPERIENCED PATIENTS | DISEASE BURDEN | General & Internal | DOUBLE-BLIND | INTERFERON-ALPHA 2A | TREATMENT-NAIVE PATIENTS | PLUS
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 10/2016, Volume 75, Issue 10, pp. 1777 - 1782
Systemic vasculitis | Autoimmune Diseases | Infections | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Prospective Studies | Cryoglobulinemia - drug therapy | Humans | Middle Aged | Male | Treatment Outcome | Vasculitis - virology | Cryoglobulinemia - virology | Antiviral Agents - administration & dosage | Sofosbuvir - administration & dosage | Ribavirin - administration & dosage | Vasculitis - drug therapy | Hepatitis C - virology | Female | Hepatitis C - complications | Drug Therapy, Combination | Hepacivirus | Usage | Care and treatment | Dosage and administration | Vasculitis | Hepatitis C virus | Ribavirin | Glomerulonephritis | Liver | Arthralgia | Peripheral neuropathy | Patients | Quality of life | Sleep disorders | Hepatitis | Side effects | Biopsy | Purpura | Ulcers | Interferon | Hepatitis C | Drug dosages | Age | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1367 - 1367
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 3736 - 3736
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 02/2018, Volume 67, Issue 2, pp. 514 - 523
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Liver Cirrhosis - etiology | Quinoxalines - adverse effects | Quinoxalines - administration & dosage | Humans | Middle Aged | Hepatitis C, Chronic - virology | Genotype | Male | Alanine Transaminase - blood | Hepatitis C, Chronic - complications | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Hepatitis C, Chronic - blood | Benzimidazoles - administration & dosage | Sulfonamides - adverse effects | Adult | Female | Aged | Sustained Virologic Response | Benzimidazoles - adverse effects | Drug Therapy, Combination | Sulfonamides - administration & dosage | Cirrhosis | Hepatitis | Clinical trials | Interferon | Hepatitis C | Patients | Ribavirin | Genotypes | Index Medicus | Life Sciences | Pharmaceutical sciences | Original
Journal Article
Joint, bone, spine : revue du rhumatisme, ISSN 1297-319X, 01/2020, Volume 87, Issue 1, pp. 85 - 85
Journal Article
Antiviral therapy, ISSN 1359-6535, 2018, Volume 23, Issue 4, pp. 307 - 314
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3473 - 3473
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 1056 - 1056
Journal Article
Transplant international, ISSN 0934-0874, 12/2016, Volume 29, Issue 12, pp. 1257 - 1265
sofosbuvir | hepatitis C virus | grazoprevir | direct‐acting antiviral agents | elbasvir | kidney transplantation | direct-acting antiviral agents | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Quinoxalines - administration & dosage | Antiviral Agents - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Imidazoles - administration & dosage | Benzofurans - administration & dosage | Genotype | Hepatitis C, Chronic - therapy | Kidney Transplantation | Polyethylene Glycols - therapeutic use | Transplant Recipients | Kidney | Kidney Failure, Chronic - therapy | Hepacivirus | Antiviral agents | Usage | Kidneys | Chronic kidney failure | Organ transplant recipients | Drug therapy | Hepatitis C virus | Genotype & phenotype | Hepatitis | Index Medicus
Journal Article